Search research articles
Contact Us
Filters
Showing results (31-40 of 80) with videos related to
Page
of 8
Sort By:
Bulletin De L'Academie Nationale De Medecine
|
June 5, 1998
[Genetic factors, Na K ATPase activity and neuropathy in diabetics]
P Vague, D Dufayet, M F Lamotte, et al.
Experimental Diabesity Research
|
June 17, 2004
C-peptide, Na+,K(+)-ATPase, and diabetes
P Vague, T C Coste, M F Jannot, et al.
Thrombosis and Haemostasis
|
August 1, 1995
Plasma plasminogen activator inhibitor activity in rats with nutritionally induced insulin resistance
V Scelles, M C Alessi, D Raccah, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 1, 1994
Modulation defect of sodium pump evidenced in diabetic patients by a microcalorimetric study
T Issautier, H Kovacic, P Gallice, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 1, 1994
SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administration
V Lassmann-Vague, D Raccah, M Pugeat, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
May 17, 2001
Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters
A Djemli-Shipkolye, T Coste, D Raccah, et al.
Diabetes & Metabolism
|
January 3, 2012
Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps
P Schaepelynck, P Darmon, L Molines, et al.
Diabetes Care
|
April 1, 1995
Immunogenicity of long-term intraperitoneal insulin administration with implantable programmable pumps. Metabolic consequences
V Lassmann-Vague, P Belicar, D Raccah, et al.
Metabolism: Clinical and Experimental
|
March 12, 2002
Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients
M F Jannot, D Raccah, D Dufayet De La Tour, et al.
Diabetes Care
|
August 1, 1994
Intraperitoneal insulin administration does not modify plasminogen activator inhibitor 1 levels in IDDM patients
D Raccah, V Lassmann-Vague, M C Alessi, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 80) with videos related to
Sort By:
Page
of 8
Bulletin De L'Academie Nationale De Medecine
|
June 5, 1998
[Genetic factors, Na K ATPase activity and neuropathy in diabetics]
P Vague, D Dufayet, M F Lamotte, et al.
Experimental Diabesity Research
|
June 17, 2004
C-peptide, Na+,K(+)-ATPase, and diabetes
P Vague, T C Coste, M F Jannot, et al.
Thrombosis and Haemostasis
|
August 1, 1995
Plasma plasminogen activator inhibitor activity in rats with nutritionally induced insulin resistance
V Scelles, M C Alessi, D Raccah, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 1, 1994
Modulation defect of sodium pump evidenced in diabetic patients by a microcalorimetric study
T Issautier, H Kovacic, P Gallice, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 1, 1994
SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administration
V Lassmann-Vague, D Raccah, M Pugeat, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
May 17, 2001
Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters
A Djemli-Shipkolye, T Coste, D Raccah, et al.
Diabetes & Metabolism
|
January 3, 2012
Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps
P Schaepelynck, P Darmon, L Molines, et al.
Diabetes Care
|
April 1, 1995
Immunogenicity of long-term intraperitoneal insulin administration with implantable programmable pumps. Metabolic consequences
V Lassmann-Vague, P Belicar, D Raccah, et al.
Metabolism: Clinical and Experimental
|
March 12, 2002
Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients
M F Jannot, D Raccah, D Dufayet De La Tour, et al.
Diabetes Care
|
August 1, 1994
Intraperitoneal insulin administration does not modify plasminogen activator inhibitor 1 levels in IDDM patients
D Raccah, V Lassmann-Vague, M C Alessi, et al.
Page
of 8